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alone, (2) patients who underwent emergent stenting as part of intraarterial recanalization therapy for acute stroke, and (3) patients who did not have pre-or poststenting MR-DWI.
Stenting Procedure
All patients received dual antiplatelet premedication (aspirin 100 mg and clopidogrel 75 mg daily) for ≥5 days before the procedure. All intracranial stenting was performed under local anesthesia. A bolus of heparin 3000 IU was administered intravenously immediately after placement of a 6F shuttle guiding sheath (Cook, Bloomington, IN) or a 6F Envoy guiding catheter (Cordis, Miami Lakes, FL) into the cervical internal carotid artery or vertebral artery. Thereafter, 1000 IU/h was administered. After completion of the procedure, heparin was stopped, but not reversed. Balloon-expandable coronary stents (Driver, Medtronic, Minneapolis, MN; FlexMaster, JOMED, Rangendingen, Germany; Vision, Guidant, St. Paul, MN) were used before the introduction of the Wingspan stent in March 2010. However, the Wingspan stent has been used exclusively since its introduction. Wingspan stenting was performed using a previously reported procedure. 18 Prestenting balloon angioplasty always preceded Wingspan stenting using the Gateway balloon. Whether or not to perform prestenting balloon angioplasty during balloon-expandable stent (BES) insertion was decided based on operator discretion. When performing prestenting balloon angioplasty before BES insertion, the smallest balloon (1.5-2.0 mm) available was used for the purpose of allowing the stent to pass through the lesion easily. Otherwise, there were no remarkable differences between BES and Wingspan stent procedure and postprocedural management.
MRI and Clinical Assessment
Except for patients with symptomatic intracranial hemorrhage, MR-DWI (field of view, 23 cm×23 cm; matrix, 128×128; b-factor, 0 and 1000; slice thickness, 3-5 mm with no gap) was obtained in all patients at least twice: within 30 days before and within 24 hours after intracranial stenting. MR-DWI was also performed if any new neurological symptom developed. Pre-and poststenting MR-DWI were analyzed by independent neuroradiologists who had not participated in the treatment. DWI (+) was defined as any newly developed high-signal intensity lesion in the relevant brain region after intracranial stenting. The relevant brain region was defined as brain parenchyma downstream of the guiding catheter, as previously reported. 9 First, DWI (+) was assessed in each patient. If present, then respective DWI (+) size, number, and volume were analyzed for each patient. The total volume of DWI (+) was calculated as the sum of the area of DWI (+) on each slice multiplied by slice thickness. In addition, the distribution of DWI (+) was stratified into 2 types: embolic-alone and stenosis-associated perforator/mixed type. Embolic-alone type was defined as DWI (+) distributed in the cortical and subcortical region distal to the target stenosis ( Figure 1 ). Stenosisassociated perforator/mixed type was defined as ≥1 DWI (+) located in the territory of the perforator which was closely related to the target stenosis regardless of the presence of distal embolic lesions ( Figure 2 ).
Each patient's neurological status was assessed by board-certified neurologists immediately after stenting and daily during admission for the development of any new or worsening neurological deficits. Clinical outcomes were evaluated at discharge, at 1 month, and at 3-month intervals thereafter. Periprocedural SIC was defined as the occurrence of any type of stroke or transient ischemic attack during admission. All technical and clinical periprocedural complications were prospectively registered into the neurointerventional and neurological database and were retrospectively evaluated.
Statistical Analysis
Statistical analysis was performed using IBM SPSS statistics version 20.0 (IBM Corp, Armonk, NY). Continuous variables with a normal Figure 1 . A 58-year-old man presenting with embolic infarctions. A, Prestenting diffusion-weighted MRI (MR-DWI) showed acute infarctions in the left occipital and temporal lobes. B, Catheter angiograms showed a severe degree of stenosis in the left intracranial vertebral artery which supplies the entire posterior circulation because of chronic occlusion of the right vertebral artery (not shown). C, Poststenting angiogram showed only a minimal residual stenosis without any angiographic abnormality. D, Poststenting MR-DWI showed acute embolic infarction in the right middle cerebellar peduncle and cerebellar hemisphere (not shown). 
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November 2014 distribution were presented as means±SD. Continuous variables without a normal distribution were presented as medians and ranges. Categorical variables were presented as percentages. Statistical analysis was performed to characterize the association between DWI (+) and possible risk factors. Statistical analysis was also performed to determine the relationship between number of DWI (+) and the distribution of DWI (+) and SIC. A χ 2 test or Fisher exact test were performed for categorical variables as appropriate. An independent t test or the Mann-Whitney U test were used for continuous variables as appropriate. The univariate cutoff for inclusion in logistic regression was P<0.20. All tests were 2-tailed. α was set at P<0.05 with a 95% confidence interval.
Results

Patient and Target ICAS Characteristics
A total of 134 patients underwent intracranial stenting. One hundred twenty-three patients (88 men and 35 women with a mean age of 64.1±9.1 years) were included in this study. Eleven patients were excluded: 9 who underwent intracranial stenting performed as a part of intra-arterial therapy for acute stroke and 2 patients because poststenting MR-DWI was not obtained as a result of hemorrhagic complications. Of the 2 patients who had poststenting hemorrhagic complication, one had intraparenchymal hemorrhage because of hyperperfusion syndrome and the other had subarachnoid hemorrhage probably because of microguidewire perforation. One hundred sixteen (94.3%) of the 123 patients were symptomatic. The location of target ICAS was the internal carotid artery in 44 (35.8%), vertebral artery in 43 (35.0%), middle cerebral artery in 20 (16.3%), and basilar artery in 16 patients (13.0%). The mean degree and length of target ICAS were 76.1±7.7% and 9.4±3.4 mm (Table 1 ).
Morbidity and Mortality of Elective Stenting
Except for emergent stenting as a part of intra-arterial therapy for acute stroke, a total of 125 patients underwent intracranial stenting. Treatment-related symptomatic complications occurred in 6 patients, 4 ischemic and 2 hemorrhagic. Treatment-related morbidity and mortality were 4.0% (5 of 125) and 0.8% (1 of 125), respectively. Table 2 ). There was no significant risk factor for SIC. Of the 43 patients with DWI (+), there was no difference in the number or in the total volume of DWI (+) between SIC and asymptomatic patients. However, SIC occurred more frequently in the perforator/mixed type than in the embolic-alone type ( Table 3 ).
MR-DWI and SIC
Discussion
MR-DWI has been used to monitor cerebral embolism after various cardiac and neurovascular procedures. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Recently, DWI (+) has been identified as a possible marker of SIC risk factors postaneurysm coiling and carotid revascularization. 5, 7, 9 However, to our knowledge, there is only one small case study of DWI (+) after intracranial angioplasty with or without stenting for ICAS. 4 In that study, DWI (+) was detected in 8 (47.1%) of the 16 patients who underwent angioplasty with (n=10) or without stenting (n=7). DWI (+) appeared more frequently after balloon angioplasty followed by stent placement than after balloon angioplasty alone or primary stent placement. Length of stenosis was also significantly correlated with DWI (+). However, that study seemed too small to identify risk factors associated with DWI (+). In this study, the incidence of DWI (+) was 35.0%, which was lower than the previous case study. Middle cerebral artery location of the target stenosis, smaller distal parent artery, and treatment-related dissection were independent risk factors for DWI (+) ( Table 1) . These independent risk factors may be associated with the difficulty of the stenting procedure. It is likely more difficult to deliver a stent to target stenoses in the middle cerebral artery than in other locations (internal carotid artery, vertebral artery, or basilar artery). This may also be true for smaller distal parent arteries. Furthermore, because dissection itself can cause overt infarction, it is not surprising that treatment-related dissection significantly increased the rate of DWI (+). Greater age is a previously documented risk factor for DWI (+) after coiling of intracranial aneurysm or carotid artery stenting. 9, 20 This suggests that greater baseline atherosclerosis and vascular tortuosity in older patients may increase microembolisms during the stenting procedure. 9, 21 In this study, greater age was a significant risk factor for DWI (+) in univariate analysis but was not significant in multivariate analysis, probably because of low statistical power. The Wingspan stent was also a risk factor in univariate analysis and showed a trend for DWI (+) in the multivariate analysis. In the recent study assessing DWI (+) after carotid artery stenting, more porous opencell stents showed a significantly higher rate of DWI (+) than closed-cell design stents. 7 The Wingspan has an open-cell design and is composed of thinner struts than the coronary BES. This may increase the rate of distal microemboli during or after stenting. Wingspan stent was a significant risk factor for embolic-only type DWI (+) on univariate analysis but did not remain significant in the logistic regression analysis ( Table I in Importantly, the rate of SIC in this study was 3.3%, all of whom showed DWI (+). However, there was no significant risk factor for SIC. This was likely because of the low incidence of SIC in this data set. Acute in-stent thrombosis occurred in 13.8% of our cases. The reported rates of in-stent thrombosis after Wingspan stenting in the previous 2 studies were 10.8% and 14.6%, respectively. 18 thrombosis can cause a severe infarction. Fortunately, acute in-stent thrombosis in our study and the previous 2 reports could be resolved by intra-arterial or intravenous glycoprotein IIb/IIIa inhibitor infusion with or without small amount of a fibrinolytic agent. As a result, there was no case of a neurological sequelae in the 3 case series including this study. 18, 22 The rate of in-stent thrombosis after Wingspan stenting seemed to be higher than that after stenting for coiling. It is likely because Wingspan stent was applied to ICAS, an entirely different neurovascular disease from aneurysm. 22 In addition, the cause of acute in-stent thrombosis may be related to resistance to antiplatelet drugs. Aspirin and clopidogrel resistance occurs in an ≈17% of patients undergoing coronary stent placement. 23 Procedure-related thromboembolic events in coil embolization occurred more frequently in nonresponder to antiplatelet premedication. 24 In our study and the previous 2 reports, antiplatelet drug resistance test was not performed routinely, and therefore, adjustment or change of antiplatelet premedication for nonresponder was not done. It might affect the rates of in-stent thrombosis and intracranial hemorrhage in our study.
Recently, Alexander et al 25 reported a proceeding in which, with adjustment or change of antiplatelet premedication for nonresponders or hyperresponder, no case of acute in-stent thrombosis or intraparenchymal hemorrhage occurred after Wingspan stenting in 154 patients. This result suggests that antiplatelet resistance test and adjustment of mediation for nonresponder or hyperresponder should be performed before intracranial stenting. In Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial, smoking was protective against ischemic stroke poststenting. Also, in our study, smoking seemed to show a protective effect against DWI (+) poststenting (Table 1) . Bang et al 26 reported that current smoking was independently and negatively correlated to poor long-term outcome after atherosclerotic stroke. Although there are still many controversies, several possible mechanisms were suggested: (1) effects of nicotine on angiogenesis or hemostasis, (2) chronic obstruction resulting in increased tissue threshold or ischemic preconditioning and enhancing collateral flows to the ischemic penumbra, and (3) short-acting increase in blood pressure as a compensatory mechanism enhancing perfusion to the ischemic penumbra. 27 Of the patients with DWI (+), there was no difference in the number or the total volume of DWI (+) between SIC and asymptomatic patients. However, SIC occurred more frequently in stenosis-associated perforator/mixed type than in embolic-alone type. This result seemed to correspond with post hoc analyses of a recent randomized controlled trial on stenting versus aggressive medical therapy for intracranial arterial stenosis. [28] [29] [30] In those analyses, most symptomatic periprocedural ischemic strokes were perforator territory infarctions (71.4%) in close proximity to the target stenosis. Unlike carotid artery stenting, where DWI (+) was exclusively caused by distal emboli from carotid atheromatous plaques or aortic arches, DWI (+) after intracranial stenting can occur because of distal emboli, perforator compromise from the snowplow effect of plaques during angioplasty, or both. Patients with prestenting perforator infarction closely related to target stenosis showed a higher perforator stroke rate after elective stenting. 31 Therefore, in line with previous studies, our results suggest that ICAS presenting with adjacent perforator ischemia may contraindicate intracranial stenting.
This study has the several limitations inherent in the retrospective nature. In addition, another limitation is that MR-DWI was not obtained between diagnostic angiography and the stenting procedure in all patients. Therefore, silent embolism during diagnostic angiography or from the target lesion between prestenting and poststenting MR might have increased the rate of DWI (+). To decrease the influence of such silent embolism on our results, only obvious new lesions in brain parenchyma downstream from the location of the guiding catheter during the stenting procedure were assessed. Pre-and poststenting cognitive functions were not assessed in this study so that the relationship between cognitive function and silent DWI (+) could not be evaluated. It may be another limitation of this study. Silent DWI (+) may affect cognitive function decline. 32 However, another studies failed to show the correlation between silent DWI (+) and cognitive function change. 33, 34 Therefore, it should be addressed in the further prospective study.
Conclusions
The incidence of DWI (+) after intracranial stenting was 35.0%. Middle cerebral artery, smaller distal parent artery, and treatment-related dissection were independent risk factors for DWI (+). Of the patients with DWI (+), there was no difference in the number or in the volume of DWI (+) between 
